Consensus recommendations for optimising the diagnosis and treatment of paroxysmal nocturnal haemoglobinuria in Singapore

夜行的 医学 儿科 内科学
作者
Yeow Tee Goh,Eng Soo Yap,Chuen Wen Tan,Daryl Tan,Yvonne Su Ming Loh,Yuh Shan Lee,Lip Leong Chong,Zi Yi Lim,Hein Than
出处
期刊:Annals Academy of Medicine Singapore [Academy of Medicine, Singapore]
卷期号:53 (6): 371-385 被引量:5
标识
DOI:10.47102/annals-acadmedsg.202475
摘要

Introduction: Paroxysmal nocturnal haemoglobinuria (PNH) is a rare haematologic disease characterised by intravascular haemolysis, thrombophilia and bone marrow failure. There is a lack of established clinical guidance on the screening, diagnosis and manage-ment of PNH in Singapore. A relatively low level of awareness among healthcare professionals regarding PNH manifestations further contributes to diagnostic delays. Additionally, limited access to complement inhibitors, like eculizumab, may delay treatment and impact patient outcomes. Method: Nine haematologists from different institu-tions in Singapore convened to formulate evidence-based consensus recommendations for optimising the diagnosis and management of patients with PNH and improving access to novel treatments. The experts reviewed the existing literature and international guidelines published from January 2010 to July 2023, focusing on 7 clinical questions spanning PNH screening, diagnostic criteria, investigations, treatment and monitoring of subclinical and classic disease, PNH with underlying bone marrow disorders, and PNH in pregnancy. A total of 181 papers were reviewed to formulate the statements. All experts voted on the statements via 2 rounds of Delphi and convened for an expert panel discussion to finetune the recommendations. Results: Sixteen statements have been formulated for optimising the screening, diagnosis and management of PNH. Upon confirmation of PNH diagnosis, individuals with active haemolysis and/or thrombosis should be considered for anti-complement therapy, with eculizumab being the only approved drug in Singapore. Conclusion: The current recommendations aim to guide the clinicians in optimising the screening, diagnosis and management of PNH in Singapore.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1234完成签到,获得积分10
1秒前
1秒前
fff完成签到,获得积分10
1秒前
超帅pzc发布了新的文献求助10
1秒前
1秒前
英吉利25发布了新的文献求助10
1秒前
乐鱼完成签到 ,获得积分10
2秒前
幸福大碗完成签到,获得积分10
2秒前
Candy发布了新的文献求助10
2秒前
Owo完成签到 ,获得积分10
2秒前
黑面白面完成签到,获得积分10
2秒前
李光辉发布了新的文献求助10
2秒前
清欢完成签到,获得积分10
2秒前
核桃发布了新的文献求助30
3秒前
晴云发布了新的文献求助10
3秒前
3秒前
Hancock完成签到 ,获得积分0
3秒前
MeiyanZou完成签到,获得积分10
3秒前
哇哈哈哈完成签到,获得积分10
3秒前
WWM完成签到,获得积分10
3秒前
3秒前
18261384109完成签到,获得积分10
3秒前
东山完成签到,获得积分10
3秒前
tingting完成签到,获得积分10
4秒前
John的应助被山楂丸采纳,获得10
4秒前
方国焱完成签到,获得积分10
4秒前
望月QAQ发布了新的文献求助10
4秒前
4秒前
4秒前
852的应助被嘦彵采纳,获得10
4秒前
小SU哥完成签到,获得积分10
5秒前
null的应助被yueyue采纳,获得10
5秒前
5秒前
5秒前
5秒前
5秒前
6秒前
Martin的应助被研友_8DoVVZ采纳,获得50
6秒前
英吉利25发布了新的文献求助10
6秒前
薄荷味的猫完成签到,获得积分0
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8152503
求助须知:如何正确求助?哪些是违规求助? 9549164
关于积分的说明 21691337
捐赠科研通 7740687
什么是DOI,文献DOI怎么找? 3425238
关于科研通互助平台的介绍 2550393
邀请新用户注册赠送积分活动 2468790